Good morning, everyone, and welcome to the middle of the week. You made it this far, so why not continue, yes? While you ponder the possibilities, we will celebrate a gorgeous morning with some needed cups of stimulation. After the unseasonable weather over the past few days, a sparkling sun is quite welcome. And of course, we are happy to pass along the latest menu of tidbits to get you started on your way. Hope you have a smashing day and do stay in touch. We accept documents and tips …

Most Americans are not aware of cancer drug shortages that might lead some patients to receive less effective or more toxic treatments, Reuters writes, citing a study in the Cancer journal. In a nationally representative survey of 420 adults, just 16 percent said they knew about shortages of oncology drugs, researchers found. Even among cancer survivors, just 31 percent were aware of drug shortages. Participants were more likely to be aware of drug shortages when they were white, older, employed, insured, and had more income and education, the study found.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy